Literature DB >> 28005075

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.

Y Zhang, G Talmon, J Wang.   

Abstract

Entities:  

Year:  2016        PMID： 28005075      PMCID： PMC5260979          DOI： 10.1038/cddis.2016.450

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


× No keyword cloud information.
Correction to: Cell Death and Disease 2015; 6: e1845. doi: 10.1038/cddis.2015.200 Since the publication of this paper the author has noticed an error in the author list, specifically that Dr. Yang Zhang is abbreviated incorrectly. The correct author list is: Yang Zhang1, G Talmon2 and J Wang3 The publisher would like to apologise for any inconvenience caused.
  10 in total

1.  TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells.

Authors:  Katie L Bailey; Ekta Agarwal; Sanjib Chowdhury; Jiangtao Luo; Michael G Brattain; Jennifer D Black; Jing Wang
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

2.  Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway.

Authors:  Gang Liu; JianPing Zhou; Ming Dong
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

Review 3.  The role and mechanisms of action of microRNAs in cancer drug resistance.

Authors:  Wengong Si; Jiaying Shen; Huilin Zheng; Weimin Fan
Journal:  Clin Epigenetics       Date:  2019-02-11       Impact factor: 6.551

4.  KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.

Authors:  Si-Si Li; Wei-Liang Jiang; Wen-Qin Xiao; Kai Li; Ye-Fei Zhang; Xing-Ya Guo; Yi-Qi Dai; Qiu-Yan Zhao; Ming-Jie Jiang; Zhan-Jun Lu; Rong Wan
Journal:  World J Gastrointest Oncol       Date:  2019-08-15

5.  A Radiogenomic Approach for Decoding Molecular Mechanisms Underlying Tumor Progression in Prostate Cancer.

Authors:  Sarah Fischer; Mohamed Tahoun; Bastian Klaan; Kolja M Thierfelder; Marc-André Weber; Bernd J Krause; Oliver Hakenberg; Georg Fuellen; Mohamed Hamed
Journal:  Cancers (Basel)       Date:  2019-09-02       Impact factor: 6.639

6.  MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer.

Authors:  Liu Ouyang; Ren-Dong Liu; De-Qiao Lei; Qing-Chao Shang; Hui-Fen Li; Xian-Gui Hu; Hao Zheng; Gang Jin
Journal:  Ann Transl Med       Date:  2021-12

7.  MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA.

Authors:  Miao Chen; Duo Wang; Junjie Liu; Zhizhan Zhou; Zhanling Ding; Lianfeng Liu; Danke Su; Hang Li
Journal:  Biomed Res Int       Date:  2020-09-05       Impact factor: 3.411

8.  CircGLCE alleviates intervertebral disc degeneration by regulating apoptosis and matrix degradation through the targeting of miR-587/STAP1.

Authors:  Zhonghui Chen; Weibing Zhang; Ming Deng; Yaming Li; Yan Zhou
Journal:  Aging (Albany NY)       Date:  2020-11-06       Impact factor: 5.682

9.  Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.

Authors:  Shuheng Bai; YinYing Wu; Yanli Yan; Shuai Shao; Jiangzhou Zhang; Jiaxin Liu; Beina Hui; Rui Liu; Hailin Ma; Xiaozhi Zhang; Juan Ren
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

Review 10.  MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets.

Authors:  Rahaba Marima; Flavia Zita Francies; Rodney Hull; Thulo Molefi; Meryl Oyomno; Richard Khanyile; Sikhumbuzo Mbatha; Mzubanzi Mabongo; David Owen Bates; Zodwa Dlamini
Journal:  Biomedicines       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.